89 related articles for article (PubMed ID: 1730880)
21. The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas.
Lin KB; Tan P; Freeman SA; Lam M; McNagny KM; Gold MR
Oncogene; 2010 Jan; 29(4):608-15. PubMed ID: 19838206
[TBL] [Abstract][Full Text] [Related]
22. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
[TBL] [Abstract][Full Text] [Related]
23. Post-transcriptional deregulation of myc genes in lung cancer cell lines.
Bernasconi NL; Wormhoudt TA; Laird-Offringa IA
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):560-5. PubMed ID: 11017923
[TBL] [Abstract][Full Text] [Related]
24. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
Schaefer A; Stöcker U; Marquardt H
J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
[TBL] [Abstract][Full Text] [Related]
25. The proto-oncogene c-myb is expressed in sporadic bovine lymphoma, but not in enzootic bovine leukosis.
Asahina M; Ishiguro N; Wu D; Goryo M; Davis WC; Okada K
J Vet Med Sci; 1996 Dec; 58(12):1169-74. PubMed ID: 8996698
[TBL] [Abstract][Full Text] [Related]
26. A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase.
Marhamati DJ; Bellas RE; Arsura M; Kypreos KE; Sonenshein GE
Mol Cell Biol; 1997 May; 17(5):2448-57. PubMed ID: 9111313
[TBL] [Abstract][Full Text] [Related]
27. Novel murine B-cell lymphoma/leukemia model to study BCL2-driven oncogenesis.
Meijerink JP; Van Lieshout EM; Beverloo HB; Van Drunen E; Mensink EJ; Macville M; Pieters R
Int J Cancer; 2005 May; 114(6):917-25. PubMed ID: 15645425
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.
Nakayama T; Higuchi T; Oiso N; Kawada A; Yoshie O
Anticancer Res; 2012 Apr; 32(4):1367-73. PubMed ID: 22493372
[TBL] [Abstract][Full Text] [Related]
29. Localization of c-MYB in differentiated cells during postnatal molar and alveolar bone development.
Lungova V; Buchtova M; Janeckova E; Tucker AS; Knopfova L; Smarda J; Matalova E
Eur J Oral Sci; 2012 Dec; 120(6):495-504. PubMed ID: 23167465
[TBL] [Abstract][Full Text] [Related]
30. The proto-oncogene c-myb mediates an intracellular calcium rise during the late G1 phase of the cell cycle.
Simons M; Morgan KG; Parker C; Collins E; Rosenberg RD
J Biol Chem; 1993 Jan; 268(1):627-32. PubMed ID: 8416967
[TBL] [Abstract][Full Text] [Related]
31. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.
Wong DM; Li L; Jurado S; King A; Bamford R; Wall M; Walia MK; Kelly GL; Walkley CR; Tarlinton DM; Strasser A; Heierhorst J
Cell Rep; 2016 Feb; 14(6):1488-1499. PubMed ID: 26832406
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous expression of mu- and gamma-chain mRNA in cloned murine B-lymphoma cell lines.
Laskov R; Ishay-Michaeli R; Wallach M; Givol D; Kim KJ
EMBO J; 1983; 2(2):167-72. PubMed ID: 11894921
[TBL] [Abstract][Full Text] [Related]
33. c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.
Fahl SP; Daamen AR; Crittenden RB; Bender TP
J Immunol; 2018 May; 200(10):3450-3463. PubMed ID: 29654210
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts.
Scortechini AR; Rupoli S; Piccinini G; Luchetti MM; Cantori I; Gabrielli A; Leoni P
Leuk Lymphoma; 1999 Apr; 33(3-4):295-304. PubMed ID: 10221509
[TBL] [Abstract][Full Text] [Related]
35. Proceedings of the 14th Mechanisms in B-cell Neoplasia meeting. Bethesda, Maryland, October 21-23, 1996.
Curr Top Microbiol Immunol; 1997; 224():1-291. PubMed ID: 9377898
[No Abstract] [Full Text] [Related]
36. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies.
Syed N; Smith P; Sullivan A; Spender LC; Dyer M; Karran L; O'Nions J; Allday M; Hoffmann I; Crawford D; Griffin B; Farrell PJ; Crook T
Blood; 2006 Jan; 107(1):250-6. PubMed ID: 16160013
[TBL] [Abstract][Full Text] [Related]
37. Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth.
Morris G; DeNardo SJ; DeNardo GL; Leshchinsky T; Wu B; Mack PC; Winthrop MD; Gumerlock PH
Biochem Mol Med; 1997 Apr; 60(2):108-15. PubMed ID: 9169090
[TBL] [Abstract][Full Text] [Related]
38. Myb proteins regulate expression of histone variant H2A.Z during thymocyte development.
Hooper J; Maurice D; Argent-Katwala MJ; Weston K
Immunology; 2008 Feb; 123(2):282-9. PubMed ID: 17931383
[TBL] [Abstract][Full Text] [Related]
39. Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients.
Ma M; Zhao R; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Hematology; 2018 Sep; 23(8):448-455. PubMed ID: 29415639
[TBL] [Abstract][Full Text] [Related]
40. B-Myb as a critical regulator of Bcl-2 in human B cells.
Meyer KB
Immunology; 2005 Jan; 114(1):23-4. PubMed ID: 15606791
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
